Shots:

• The designation allows Zai Lab to take advantage of an expedited approval procedure for Optune offering opportunities for pre-consultation with an input from the NMPA throughout the approval process
• In Sept 2018- Zai Lab and Novocure signed an exclusive license agreement for Tumor Treating Fields- including the brand name Optune for Greater China. Additionally- in H2’18 Zai Lab has also launched the product in Hong Kong for treatment of glioblastoma (GBM)
• Optune is a tumor treating delivery system that utilizes electric fields of specific frequencies to disrupt cancer cell division- inhibiting tumor growth and causing affected cancer cells to die and is marketed in the US- EU- Japan and certain other countries for the treatment of GBM  

Click here to­ read full press release/ article | Ref: Zai Lab| Image: Behance